Comments on: PARPAML: A Phase 1 Protocol for Relapsed Pediatric AML to Determine the Safety and Efficacy of the PARP Inhibitor Talazoparib in Combination with Chemotherapy

Comments on: PARPAML: A Phase 1 Protocol for Relapsed Pediatric AML to Determine the Safety and Efficacy of the PARP Inhibitor Talazoparib in Combination with Chemotherapy https://poeticphase1.org/faq-items/parpaml/ Early Phase Clinical Trials in Pediatric Oncology Sat, 22 Jun 2024 01:16:22 +0000 hourly 1 https://wordpress.org/?v=6.9.4